- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07565376
Effects of Exercise-Induced Muscle Damage on Neuromuscular Complexity (EIMD-NMC)
Effects of Exercise-Induced Muscle Damage Induced by Eccentric Exercise on Knee Extensor Torque, Oxygenation, and Electromyographic Properties: A Complexity-Based Approach
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
The present study was designed to investigate the impact of exercise-induced muscle damage , caused by eccentric exercise, on neuromuscular and physiological function of the knee extensor muscles. The research was based on the contemporary theoretical framework of the "loss of complexity," which proposes that physiological signal variability is not merely random noise, but rather an essential characteristic of healthy and adaptable biological systems. According to this approach, greater signal complexity reflects a more flexible and efficient neuromuscular control strategy, whereas reduced complexity indicates impaired adaptability and a more rigid functional state.
A total of eleven healthy young men (N = 11, age 27.8 ± 2.5 years) participated in the study. During the initial session, anthropometric characteristics were recorded and maximal voluntary isometric torque of the knee extensors was measured. The main testing procedure involved a sustained submaximal isometric contraction performed at 50% of maximal voluntary contraction for 60 seconds. During this task, torque output, muscle oxygenation, and electromyographic activity of the vastus lateralis were continuously was recorded in order to assess both mechanical and neuromuscular responses.
Following baseline testing, participants completed a muscle damage induction protocol consisting of five sets of fifteen maximal eccentric contractions performed at an angular velocity of 60°/s. This protocol was designed to induce structural and functional muscle impairment characteristic of exercise induced muscle damage. Forty-eight hours after the intervention, all measurements were repeated to determine the effects of muscle damage on the same variables. Data were processed and analyzed in MATLAB, with statistical significance set at p < .05.
The results are anticipated to confirm the successful induction of muscle damage.
The investigators wanted to show the effect of exercise induced muscle damage on torque complexity through changes in Sample Entropy, and changes on detrended fluctuation analysis exponent, which indicate that torque fluctuations will became more regular, predictable, and less complex.
A possible reduction in complexity it expected to be accompanied by a change in neuromuscular efficiency, meaning that a greater level of neural activation will be needed to produce the same relative mechanical output. A likely explanation is that damage to muscle fibers and sarcomeres would reduce the effectiveness of force transmission, forcing the nervous system to compensate through increased neural drive.
In parallel, it is expected that muscle oxygenation measurements will show increased deoxygenated hemoglobin, indicating higher oxygen extraction and a greater metabolic burden on the remaining functional muscle fibers. This finding would suggest that, after exercise induced muscle damage, fewer intact fibers may be available to share the workload, thereby increasing the relative demand placed on those still functioning effectively.
An additional important observation will be the possible changes in traditional linear variability indices, such as standard deviation and coefficient of variation. This will highlight the limitation of conventional linear measures in detecting subtle but functionally meaningful changes in neuromuscular regulation.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Attica
-
Athens, Attica, Grekland, 17234
- School of Physical Education and Sport Science
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- No experience of resistance exercise with heavy loads the past 6 months
Exclusion Criteria:
- History of lower-limb injury
- Taking any medication
- Suffered from any pathological condition
- Participation in a systematic eccentric exercise program during the previous 6 months
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Övrig
- Tilldelning: Icke-randomiserad
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Eccentric exercise
All the parameters that was assessed 48 hours post isokinetic eccentric exercise
|
Isokinetic eccentric exercise consisted of 5 sets of 15 repetitions using the knee extensors.
The intensity of the exercise was the maximal voluntary and an interval of 1 minute was applied between sets.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Isokinetic sub maximal exercise
Tidsram: From enrollment to the end of the treatment at 48 hours
|
Isokinetic exercise of 60 seconds using the sub maximal intensity of 50% MVC.
The knee joint will be set at 90 degrees and the values will be in Nm.
|
From enrollment to the end of the treatment at 48 hours
|
|
Electromyography
Tidsram: From enrollment to the end of treatment at 48 hours
|
Continuous recording of EMG during the 60 seconds isometric exercise.
Patches will be placed in vastus laterals and the recording will be at 100 Hz
|
From enrollment to the end of treatment at 48 hours
|
|
Muscle oxygenation
Tidsram: rom enrollment to the end of treatment at 48 hours
|
Muscle oxygenation measured using near infrared spectroscopy (NIRS) of the knee extensors during the 60 seconds isometric exercise.
The main parameters that will be recored are the oxygenated haemoglobin, the deoxygenated haemoglobin, the total haemoglobin and the difference between oxygenated and deoxygenated haemoglobin.
|
rom enrollment to the end of treatment at 48 hours
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Delayed onset muscle soreness
Tidsram: From enrollment to the end of treatment at 48 hours
|
Assessment of subjective pain feeling assessed by palpation of knee extensors muscle belly.
The scale was set between 1 (no pain at all) to 10 (extreme pain).
|
From enrollment to the end of treatment at 48 hours
|
|
Range of Motion
Tidsram: From enrollment to the end of treatment at 48 hours
|
The angles the knee joint may be flexed without the feeling of any pain.
The starting position was set at full extension.
|
From enrollment to the end of treatment at 48 hours
|
|
Peak torque output
Tidsram: From enrollment to the end of treatment at 48 hours
|
Isometric peak torque output was assessed at 90 degrees knee joint angle (0 degrees was set at full extension).
The assessments was consisted of 3 set of 5 seconds each.
The higher performance was recorded for the data analysis
|
From enrollment to the end of treatment at 48 hours
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Vassilis Paschalis, Dr., National and Kapodistrian Univesity of Athens
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Andra studie-ID-nummer
- 1731/19-12-2024
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .